Summary
A group of 23 student volunteers were each inoculated intranasally with 400 IU of inactivated, freeze-dried A/England/42/72 vaccine. Only one volunteer showed a four-fold rise in serum HI antibody following immunization, and the mean increase in serum HI antibody (gmt) for all volunteers did not increase two-fold. Thirteen of the volunteers developed detectable levels of nasal wash neutralizing antibody after immunization; local antibody was most commonly found in volunteers who also produced a detectable but less than four-fold rise in serum antibody titre, and who produced nasal washings with relatively high concentrations of protein and secretory IgA. Four weeks after immunization, the vaccinees and a matched group of control subjects were inoculated with attenuated A/England/42/72 (MRC-7) virus. Evidence of infection was found in 14 of 23 (61 per cent) of control subjects and in seven of 23 (30 per cent) of immunized volunteers. This result showed a significant protection (P=0.04) against challenge virus infection for volunteers given intranasal vaccine.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Couch, R. B., Douglas, R. G., Rossen, R., Kasel, J. A.: Role of secretory antibody in influenza. In: The Secretory Immune System, pp. 93–113. U.S. Department of Public Health. 1969.
Davenport, F. M., Hennessy, A. V., Brandon, F. M., Webster, R. G., Barrett, C. D. Jr., Lease, G. O.: Comparisons of serological and febrile responses in humans to vaccination with influenza A viruses and their haemagglutinins. Labor. clin. Med.63, 5–13 (1964).
Downie, J. C., Stuart-Harris, C. H.: The production of neutralizing activity in serum and nasal secretion following immunization with influenza B virus. J. Hyg. (Cambridge),68, 233–244 (1970).
Fahey, J. L., McLaughlin, C.: Preparation of antisera specific for 6.6 S γ-globulins, β2A-globulins, γ-macroglobulins and for type I and II common γ-globulin determinants. J. Immunol.91, 484–497 (1963).
Fazekas de St. Groth, S., Withell, J., Lafferty, K. J.: An improved assay for neutralization antibodies against influenza viruses. J. Hyg. (Cambridge).56, 415–426 (1958).
Gwaltney, J. M., Jr., Edmondson, W. P., Jr., Rothenberg, R., White, P. W.: A comparison of subcutaneous, nasal and combined vaccination. I. Antigenicity. Amer. J. Epidemiol.93, 472–479 (1971).
Haigh, W., Howell, R. W.: The efficacy of the A2/Aichi/68 strain in inhaled influenza immunization against A/England/42/72 variant. J. Soc. Occupational Med.23, 125–127 (1973).
Haigh, W., Howell, R. W., Meichen, F. W.: A comparative trial of influenza immunization by inhalation and hypojet methods. The Practitioner211, 365–370 (1973).
Hobson, D., Beare, A. S., Ward-Gardner, A.: Haemagglutinin-inhibiting serum antibody titres as an index of response of volunteers to intranasal infection with live, attenuated strain of influenza virus. Proceedings of the Symposium of Live Influenza Vaccines, Zagreb, 1971, pp. 73–84 (Yugoslav Academy of Science and Arts, 1972).
Kasel, J. A., Horne, E. B., Fulk, R. V., Togo, Y., Huber, M., Hornick, R. B.: Antibody responses in nasal secretions and serum of elderly persons following local and parenteral immunization of inactivated influenza virus vaccines. J. Immunol.102, 555–562 (1969).
Liem, K. S., Marcus, E. A., Jacob, J., van Strick, R.: The protective effect of intranasal immunization with inactivated influenza virus vaccine. Postgrad. med. J.49, 175–179 (1973).
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the Folin phenol reagent. J. biol. Chem.193, 265–275 (1951).
Mancini, G., Carbonara, A. O., Heremans, J. F.: Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochem.2, 235–254 (1965).
Meiklejohn, G., Kempe, C. H., Tahalman, W. G., Lennette, E. H.: Evaluation of monovalent influenza vaccines. II. Observations during an influenza A-prime epidemic. Amer. J. Hyg.55, 12–21 (1952).
Perkins, J. C., Tucker, D. N., Knoft, H. L. S., Wenzel, R. P., Kapikian, A. Z., Chanock, R. M.: Evidence for the protective effect of an inactivated rhinovirus vaccine given by the nasal route. Amer. J. Epidemiol.90, 319–326 (1969).
Potter, C. W., Stuart-Harris, C. H., McLaren, C.: Antibody in respiratory secretions following immunization with influenza virus vaccines. International Symposium on Influenza vaccines in man and horses, London, 1972. Symposium Series Immunobiological Standards,20, 198–207 (1973).
Potter, C. W., Jennings, R., McLaren, C., Clarke, A.: Immune response in volunteers to intranasal inoculation with freeze-dried influenza A/Hong Kong/68 vaccine. J. biol. Stand. (in press) (1975).
Quilligan, J. J., Francis, T., Jr., Minuse, E.: Reactions to an influenza virus vaccine in infants and children. Amer. J. Dis. Child.78, 295–301 (1949).
Reed, L. J., Muench, H.: A simple method for estimating 50 per cent endpoints. Amer. J. Hyg.27, 493–497 (1938).
Rosenbaum, M. J., Mammen, R. E., Edwards, E. A., Frazier, W. E., Peckinpaugh, R. O., Tauraso, N. M.: Effect of dose and route of immunization on the antibody response of humans to A/PR/8/34 (H0N1) influenza vaccine. International Symposium on influenza in man and horses, London, 1972. Symposium Series Immunobiological Standards20, 191–197 (1973).
Sever, J. L.: Application of a microtechnique to viral serological investigations. J. Immunol.88, 320–329 (1962).
Shore, S. L., Potter, C. W., Stuart-Harris, C. H.: Antibody response to inactivated influenza vaccine given by different routes in patients with chronic bronchopulmonary disease. Thorax28, 721–728 (1974).
Smith, C. B., Purcell, R. H., Bellanti, J. A., Chanock, R. M.: Protective effect of antibody to para-influenza type I virus. New Engl. J. Med.275, 1145–1152 (1966).
Waldman, R. H., Kasel, J. A., Fulk, R. V., Mann, J. J., Togo, Y., Hornick, R. B., Heiner, G. T., Dawkins, A. T.: Influenza antibody in human respiratory secretion following subcutaneous or nasopharyngeal immunization with inactivated vaccine. Nature,218, 594–595 (1968).
Waldman, R. H., Mann, J. J., Small, P. A., Jr.: Immunization against influenza: prevention of illness in man by aerosolized inactivated vaccine. J. Amer. Med. Ass.207, 520–524 (1969).
Waldman, R. H., Wood, S. H., Torres, E. J., Small, P. A., Jr.: Influenza antibody response following aerosol administration of inactivated virus. Amer. J. Epidemiol.91, 575–584 (1970).
Waldman, R. H., Coggins, W. J.: Influenza Immunization: Field trial on a University campus. J. infect. Dis.126, 242–248 (1972).
Wenzel, R. P., Hendley, J. O., Sande, M. A., Gwaltney, J. M., Jr.: Revised (1972 to 1973) bivalent influenza vaccine. J. Amer. Med. Ass.226, 435–438 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Potter, C.W., Jennings, R., McLaren, C. et al. Immunity following intranasal administration of an inactivated, freeze-dried A/England/42/72 vaccine. Archives of Virology 48, 307–316 (1975). https://doi.org/10.1007/BF01317429
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01317429